EQUINOX NEPREMICNINE d.d. (LJSE:EQNX)
64.00
+0.50 (0.79%)
At close: Sep 1, 2026
-2.29% (1Y)
| Market Cap | 113.86M -2.7% |
| Revenue (ttm) | 9.54M -1.8% |
| Net Income | 2.83M +118.1% |
| EPS | 1.59 +119.8% |
| Shares Out | 1.79M |
| PE Ratio | 39.98 |
| Forward PE | n/a |
| Dividend | 2.00 (3.15%) |
| Ex-Dividend Date | Jun 18, 2026 |
| Volume | 14 |
| Open | 64.00 |
| Previous Close | 63.50 |
| Day's Range | 64.00 - 64.00 |
| 52-Week Range | 59.00 - 65.50 |
| Beta | -0.00 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 21, 2026 |